SCHEMBL3846294

SCHEMBL3846294

Cc1ccnc(N2Cc3cc(Br)ccc3C2=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
BACE1 P56817 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
SLC11A2 P49281 1/20 0.39
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
PKM P14618 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CBLB Q13191 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15344937 0.77 MAP3K5 (0.41) CYP3A4CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL29209101 0.76 MYLK (0.44) BACE1SLC11A2NPC1CBLBMEN1
SCHEMBL3852007 0.76 CYP3A4 (0.36) CYP3A4CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL3847373 0.74 NPC1 (0.60) BACE1SLC11A2NPC1SMN1; SMN2MEN1
SCHEMBL7601380 0.72 NPC1 (0.50) CYP3A4CYP2C19BACE1RAB9ANPC1
SCHEMBL13874764 0.71 MAP3K5 (0.34) CYP3A4GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3051492 0.70 NPC1 (0.65) CYP3A4CYP2C19BACE1RAB9ANPC1
SCHEMBL1950816 0.69 SLC11A2 (0.56) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL25390515 0.69 MAP3K14 (0.55) CYP3A4CYP2C9CYP2C19BACE1GRIN2D
SCHEMBL30471847 0.69 MAP3K14 (0.55) CYP3A4CYP2C9CYP2C19BACE1GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed